ClinicalTrials.gov
public full text
Public Domain
Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans
To determine if senolytic drugs reduce senescent cell burden and reduce bone resorption markers/increase bone formation markers in elderly women.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Senolytics to Improve Osteoporosis Therapy#1162215
- Closing the gap in aging science: unlocking the potential of nanoparticles in senescence therapy#1136600
- Peri-operative Inflammaging in the Elderly After Surgery#838677
- Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity#969407
- Urinary detection of therapy-induced senescence and fibrosis using an injectable albumin-based nanoprobe.#218984
Record · ID 1032895
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive